1. Llor, C, Bjerrum, L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf 2014;5:229–241.
3. Tamma, PD, Avdic, E, Li, DX, Dzintars, K, Cosgrove, SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 2017;177:1308–1315.
4. Lode, H. Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections. Am J Med 2010;123(4 Suppl):S26–S38.
6. Brown, J, Doloresco, F III, Mylotte, JM. “Never events”: not every hospital-acquired infection is preventable. Clin Infect Dis 2009;49:743–746.
7. Glowacki, RC, Schwartz, DN, Itokazu, GS, Wisniewski, MF, Kieszkowski, P, Weinstein, RA. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis 2003;37:59–64.
8. Zalmanovici Trestioreanu, , A
1, Lador, , A, Sauerbrun-Cutler, , MT, Leibovici, , L. Antibiotics for asymptomatic bacteriuria. Cochrane Database Syst Rev 2015;4:CD009534.
9. Shiley, KT, Lautenbach, E, Lee, I. The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics? Infect Control Hosp Epidemiol 2010;31:1177–1183.
10. Berger, ER, Greenberg, CC, Bilimoria, KY. Challenges in reducing surgical “never events.” JAMA 2015;314:1386–1387.
11. Milstein, A. Ending extra payment for “never events”—stronger incentives for patients’ safety. N Engl J Med 2009;360:2388–2390.